A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 40
- Registration Number
- NCT06716190
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems
- Conditions
- Liver DiseasesHealthy
- Interventions
- Drug: Zongertinib (BI 1810631)
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 28
- Registration Number
- NCT06692322
- Locations
- 🇺🇸
American Research Corporation at the Texas Liver Institute, San Antonio, Texas, United States
A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH
- Conditions
- Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
- Interventions
- Drug: Placebo for BI 770371
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT06675929
- Locations
- 🇺🇸
Southern California Research Center, Coronado, California, United States
🇺🇸Catalina Research Institute, LLC-Montclair-49051, Montclair, California, United States
🇺🇸Knowledge Research Center, Orange, California, United States
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT06655220
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT06647810
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: BI 3032950 intravenous (Part A)Drug: BI 3032950 subcutaneous (Part B)
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 40
- Registration Number
- NCT06636656
- Locations
- 🇺🇸
Peak Gastroenterology Associates, Colorado Springs, Colorado, United States
🇧🇪AZ Maria Middelares, Gent, Belgium
🇧🇪UZ Leuven, Leuven, Belgium
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Conditions
- Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1800
- Registration Number
- NCT06632444
- Locations
- 🇺🇸
Arizona Liver Health-Chandler-68733, Chandler, Arizona, United States
🇺🇸The Institute for Liver Health, LLC, Tucson, Arizona, United States
🇺🇸Arizona Liver Health - Peoria 85381, Peoria, Arizona, United States
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Conditions
- Metabolic Dysfunction Associated Steatohepatitis
- Interventions
- Drug: Placebo matching survodutide
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1590
- Registration Number
- NCT06632457
- Locations
- 🇪🇸
Hospital La Paz, Madrid, Spain
🇪🇸Hospital Puerta de Hierro, Majadahonda, Spain
🇨🇳Tianjin Second People's Hospital, Tianjin Shi, China
A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT06631430
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT06631417
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany